More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to ...

Insulin then lowers your blood sugar levels in several ways. On the other hand, when your blood sugar levels drop too low, your pancreas releases the hormone glucagon, which raises your blood ...

According to nutritionist Ángela Quintas it all comes down to what you’re eating—and, more specifically, how it impacts your ...

A Cell Metabolism study finds that while high-GI meals spike insulin and glucose, they don’t increase hunger or consistently ...

For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

A feedback system lets the body know when no more glucagon is needed. When everything works correctly, the body will produce insulin to move glucose out of the blood and into the cells to ...

Researchers analysed data from 150 adults with T1D, divided into semaglutide, tirzepatide, and control groups.

A Columbia University dermatologist argues that physicians in her specialty should be on the lookout for metabolic syndrome ...

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor ... developing hematologic cancers compared with insulin and metformin use, according to a research ...